BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23876358)

  • 1. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
    De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
    Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
    De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA
    Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
    Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
    Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CT and MR-CT fusion for prostate post-implant dosimetry.
    Maletz KL; Ennis RD; Ostenson J; Pevsner A; Kagen A; Wernick I
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1912-7. PubMed ID: 21550183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
    Bowes D; Crook JM; Araujo C; Batchelar D
    Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
    Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
    Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
    Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
    Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
    Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
    Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry.
    Sanders JW; Tang C; Kudchadker RJ; Venkatesan AM; Mok H; Hanania AN; Thames HD; Bruno TL; Starks C; Santiago E; Cunningham M; Frank SJ
    Brachytherapy; 2023; 22(6):822-832. PubMed ID: 37716820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of interobserver differences in postimplant dosimetry following prostate brachytherapy and the efficacy of CT/MRI fusion imaging.
    Aoki M; Yorozu A; Dokiya T
    Jpn J Radiol; 2009 Nov; 27(9):342-7. PubMed ID: 19943144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
    Xue J; Waterman F; Handler J; Gressen E
    Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy.
    Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of MRI pulse sequences in defining prostate volume after permanent implantation.
    McLaughlin PW; Narayana V; Drake DG; Miller BM; Marsh L; Chan J; Gonda R; Winfield RJ; Roberson PL
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):703-11. PubMed ID: 12377321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.
    Watanabe K; Katayama N; Katsui K; Matsushita T; Takamoto A; Ihara H; Nasu Y; Takemoto M; Kuroda M; Kanazawa S
    J Radiat Res; 2019 Jul; 60(4):483-489. PubMed ID: 31083713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy.
    Katayama N; Takemoto M; Yoshio K; Katsui K; Uesugi T; Nasu Y; Matsushita T; Kaji M; Kumon H; Kanazawa S
    J Radiat Res; 2011; 52(5):680-4. PubMed ID: 21857148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants.
    Acher P; Rhode K; Morris S; Gaya A; Miquel M; Popert R; Tham I; Nichol J; McLeish K; Deehan C; Dasgupta P; Beaney R; Keevil SF
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1518-25. PubMed ID: 18513881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deformable registration of x ray and MRI for postimplant dosimetry in low dose rate prostate brachytherapy.
    Hrinivich WT; Park S; Le Y; Song DY; Lee J
    Med Phys; 2019 Sep; 46(9):3961-3973. PubMed ID: 31215042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CT- and radiograph-based post-implant dosimetry for transperineal 125I prostate brachytherapy using single seeds and a commercial treatment-planning software.
    Siebert FA; Kohr P; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):96-101. PubMed ID: 16447016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
    Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
    Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T
    Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.